Global Rituximab Biosimilars Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Description

The Rituximab Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Rituximab Biosimilars market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.

The Rituximab Biosimilars market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.

Hospital Pharmacy occupied for % of the Rituximab Biosimilars global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, 500mg segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Rituximab Biosimilars include Amgen, AryoGen Pharmed, Biocad, Cadila Pharmaceuticals and Celltrion, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Key Features of This Report:
This report provides in-depth analysis of the global Rituximab Biosimilars market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main Rituximab Biosimilars manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This reports profiles key players in the global Rituximab Biosimilars market based on the following parameters – headquarters, production locations, products portfolio, Rituximab Biosimilars revenue, sales, average price and gross margin, recent developments.

Evaluation and forecast the Rituximab Biosimilars market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
Rituximab Biosimilars market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type (2017-2028; USD Million)
    500mg
    100mg
    Other

Market segment by Application (2017-2028; USD Million)
    Hospital Pharmacy
    Retail Pharmacy

The key market players for global Rituximab Biosimilars market are listed below:
    Amgen
    AryoGen Pharmed
    Biocad
    Cadila Pharmaceuticals
    Celltrion
    Dr Reddy’s Laboratories
    Teva
    Hetero Group
    Innovent Biologics
    Intas Biopharmaceuticals
    Mylan
    Probiomed
    TRPharma
    Zenotech Laboratories

Region Segment (2017-2028; USD Million)
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rituximab Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rituximab Biosimilars, with price, sales, revenue and global market share of Rituximab Biosimilars from 2019 to 2022.
Chapter 3, the Rituximab Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rituximab Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Rituximab Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rituximab Biosimilars.
Chapter 13, 14, and 15, to describe Rituximab Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Rituximab Biosimilars Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Rituximab Biosimilars Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 500mg
        1.2.3 100mg
        1.2.4 Other
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Rituximab Biosimilars Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
    1.4 Global Rituximab Biosimilars Market Size & Forecast
        1.4.1 Global Rituximab Biosimilars Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Rituximab Biosimilars Sales in Volume (2017-2028)
        1.4.3 Global Rituximab Biosimilars Price (2017-2028)
    1.5 Global Rituximab Biosimilars Production Capacity Analysis
        1.5.1 Global Rituximab Biosimilars Total Production Capacity (2017-2028)
        1.5.2 Global Rituximab Biosimilars Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Rituximab Biosimilars Market Drivers
        1.6.2 Rituximab Biosimilars Market Restraints
        1.6.3 Rituximab Biosimilars Trends Analysis

2 Manufacturers Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Rituximab Biosimilars Product and Services
        2.1.4 Amgen Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 AryoGen Pharmed
        2.2.1 AryoGen Pharmed Details
        2.2.2 AryoGen Pharmed Major Business
        2.2.3 AryoGen Pharmed Rituximab Biosimilars Product and Services
        2.2.4 AryoGen Pharmed Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Biocad
        2.3.1 Biocad Details
        2.3.2 Biocad Major Business
        2.3.3 Biocad Rituximab Biosimilars Product and Services
        2.3.4 Biocad Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Cadila Pharmaceuticals
        2.4.1 Cadila Pharmaceuticals Details
        2.4.2 Cadila Pharmaceuticals Major Business
        2.4.3 Cadila Pharmaceuticals Rituximab Biosimilars Product and Services
        2.4.4 Cadila Pharmaceuticals Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Celltrion
        2.5.1 Celltrion Details
        2.5.2 Celltrion Major Business
        2.5.3 Celltrion Rituximab Biosimilars Product and Services
        2.5.4 Celltrion Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Dr Reddy’s Laboratories
        2.6.1 Dr Reddy’s Laboratories Details
        2.6.2 Dr Reddy’s Laboratories Major Business
        2.6.3 Dr Reddy’s Laboratories Rituximab Biosimilars Product and Services
        2.6.4 Dr Reddy’s Laboratories Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Teva
        2.7.1 Teva Details
        2.7.2 Teva Major Business
        2.7.3 Teva Rituximab Biosimilars Product and Services
        2.7.4 Teva Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Hetero Group
        2.8.1 Hetero Group Details
        2.8.2 Hetero Group Major Business
        2.8.3 Hetero Group Rituximab Biosimilars Product and Services
        2.8.4 Hetero Group Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Innovent Biologics
        2.9.1 Innovent Biologics Details
        2.9.2 Innovent Biologics Major Business
        2.9.3 Innovent Biologics Rituximab Biosimilars Product and Services
        2.9.4 Innovent Biologics Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Intas Biopharmaceuticals
        2.10.1 Intas Biopharmaceuticals Details
        2.10.2 Intas Biopharmaceuticals Major Business
        2.10.3 Intas Biopharmaceuticals Rituximab Biosimilars Product and Services
        2.10.4 Intas Biopharmaceuticals Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Mylan
        2.11.1 Mylan Details
        2.11.2 Mylan Major Business
        2.11.3 Mylan Rituximab Biosimilars Product and Services
        2.11.4 Mylan Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Probiomed
        2.12.1 Probiomed Details
        2.12.2 Probiomed Major Business
        2.12.3 Probiomed Rituximab Biosimilars Product and Services
        2.12.4 Probiomed Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 TRPharma
        2.13.1 TRPharma Details
        2.13.2 TRPharma Major Business
        2.13.3 TRPharma Rituximab Biosimilars Product and Services
        2.13.4 TRPharma Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Zenotech Laboratories
        2.14.1 Zenotech Laboratories Details
        2.14.2 Zenotech Laboratories Major Business
        2.14.3 Zenotech Laboratories Rituximab Biosimilars Product and Services
        2.14.4 Zenotech Laboratories Rituximab Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Rituximab Biosimilars Breakdown Data by Manufacturer
    3.1 Global Rituximab Biosimilars Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Rituximab Biosimilars Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Rituximab Biosimilars
    3.4 Market Concentration Rate
        3.4.1 Top 3 Rituximab Biosimilars Manufacturer Market Share in 2021
        3.4.2 Top 6 Rituximab Biosimilars Manufacturer Market Share in 2021
    3.5 Global Rituximab Biosimilars Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Rituximab Biosimilars Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Rituximab Biosimilars Market Size by Region
        4.1.1 Global Rituximab Biosimilars Sales in Volume by Region (2017-2028)
        4.1.2 Global Rituximab Biosimilars Revenue by Region (2017-2028)
    4.2 North America Rituximab Biosimilars Revenue (2017-2028)
    4.3 Europe Rituximab Biosimilars Revenue (2017-2028)
    4.4 Asia-Pacific Rituximab Biosimilars Revenue (2017-2028)
    4.5 South America Rituximab Biosimilars Revenue (2017-2028)
    4.6 Middle East and Africa Rituximab Biosimilars Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Rituximab Biosimilars Sales in Volume by Type (2017-2028)
    5.2 Global Rituximab Biosimilars Revenue by Type (2017-2028)
    5.3 Global Rituximab Biosimilars Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Rituximab Biosimilars Sales in Volume by Application (2017-2028)
    6.2 Global Rituximab Biosimilars Revenue by Application (2017-2028)
    6.3 Global Rituximab Biosimilars Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Rituximab Biosimilars Sales by Type (2017-2028)
    7.2 North America Rituximab Biosimilars Sales by Application (2017-2028)
    7.3 North America Rituximab Biosimilars Market Size by Country
        7.3.1 North America Rituximab Biosimilars Sales in Volume by Country (2017-2028)
        7.3.2 North America Rituximab Biosimilars Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Rituximab Biosimilars Sales by Type (2017-2028)
    8.2 Europe Rituximab Biosimilars Sales by Application (2017-2028)
    8.3 Europe Rituximab Biosimilars Market Size by Country
        8.3.1 Europe Rituximab Biosimilars Sales in Volume by Country (2017-2028)
        8.3.2 Europe Rituximab Biosimilars Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Rituximab Biosimilars Sales by Type (2017-2028)
    9.2 Asia-Pacific Rituximab Biosimilars Sales by Application (2017-2028)
    9.3 Asia-Pacific Rituximab Biosimilars Market Size by Region
        9.3.1 Asia-Pacific Rituximab Biosimilars Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Rituximab Biosimilars Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Rituximab Biosimilars Sales by Type (2017-2028)
    10.2 South America Rituximab Biosimilars Sales by Application (2017-2028)
    10.3 South America Rituximab Biosimilars Market Size by Country
        10.3.1 South America Rituximab Biosimilars Sales in Volume by Country (2017-2028)
        10.3.2 South America Rituximab Biosimilars Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Rituximab Biosimilars Sales by Type (2017-2028)
    11.2 Middle East & Africa Rituximab Biosimilars Sales by Application (2017-2028)
    11.3 Middle East & Africa Rituximab Biosimilars Market Size by Country
        11.3.1 Middle East & Africa Rituximab Biosimilars Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Rituximab Biosimilars Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Rituximab Biosimilars and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Rituximab Biosimilars
    12.3 Rituximab Biosimilars Production Process
    12.4 Rituximab Biosimilars Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Rituximab Biosimilars Typical Distributors
    13.3 Rituximab Biosimilars Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Rituximab Biosimilars Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Rituximab Biosimilars Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Amgen Basic Information, Manufacturing Base and Competitors
    Table 4. Amgen Major Business
    Table 5. Amgen Rituximab Biosimilars Product and Services
    Table 6. Amgen Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. AryoGen Pharmed Basic Information, Manufacturing Base and Competitors
    Table 8. AryoGen Pharmed Major Business
    Table 9. AryoGen Pharmed Rituximab Biosimilars Product and Services
    Table 10. AryoGen Pharmed Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Biocad Basic Information, Manufacturing Base and Competitors
    Table 12. Biocad Major Business
    Table 13. Biocad Rituximab Biosimilars Product and Services
    Table 14. Biocad Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 16. Cadila Pharmaceuticals Major Business
    Table 17. Cadila Pharmaceuticals Rituximab Biosimilars Product and Services
    Table 18. Cadila Pharmaceuticals Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Celltrion Basic Information, Manufacturing Base and Competitors
    Table 20. Celltrion Major Business
    Table 21. Celltrion Rituximab Biosimilars Product and Services
    Table 22. Celltrion Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
    Table 24. Dr Reddy’s Laboratories Major Business
    Table 25. Dr Reddy’s Laboratories Rituximab Biosimilars Product and Services
    Table 26. Dr Reddy’s Laboratories Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Teva Basic Information, Manufacturing Base and Competitors
    Table 28. Teva Major Business
    Table 29. Teva Rituximab Biosimilars Product and Services
    Table 30. Teva Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Hetero Group Basic Information, Manufacturing Base and Competitors
    Table 32. Hetero Group Major Business
    Table 33. Hetero Group Rituximab Biosimilars Product and Services
    Table 34. Hetero Group Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Innovent Biologics Basic Information, Manufacturing Base and Competitors
    Table 36. Innovent Biologics Major Business
    Table 37. Innovent Biologics Rituximab Biosimilars Product and Services
    Table 38. Innovent Biologics Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Intas Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 40. Intas Biopharmaceuticals Major Business
    Table 41. Intas Biopharmaceuticals Rituximab Biosimilars Product and Services
    Table 42. Intas Biopharmaceuticals Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. Mylan Basic Information, Manufacturing Base and Competitors
    Table 44. Mylan Major Business
    Table 45. Mylan Rituximab Biosimilars Product and Services
    Table 46. Mylan Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 47. Probiomed Basic Information, Manufacturing Base and Competitors
    Table 48. Probiomed Major Business
    Table 49. Probiomed Rituximab Biosimilars Product and Services
    Table 50. Probiomed Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 51. TRPharma Basic Information, Manufacturing Base and Competitors
    Table 52. TRPharma Major Business
    Table 53. TRPharma Rituximab Biosimilars Product and Services
    Table 54. TRPharma Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 55. Zenotech Laboratories Basic Information, Manufacturing Base and Competitors
    Table 56. Zenotech Laboratories Major Business
    Table 57. Zenotech Laboratories Rituximab Biosimilars Product and Services
    Table 58. Zenotech Laboratories Rituximab Biosimilars Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 59. Global Rituximab Biosimilars Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
    Table 60. Global Rituximab Biosimilars Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 61. Market Position of Manufacturers in Rituximab Biosimilars, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 62. Global Rituximab Biosimilars Production Capacity by Company, (K Units): 2020 VS 2021
    Table 63. Head Office and Rituximab Biosimilars Production Site of Key Manufacturer
    Table 64. Rituximab Biosimilars New Entrant and Capacity Expansion Plans
    Table 65. Rituximab Biosimilars Mergers & Acquisitions in the Past Five Years
    Table 66. Global Rituximab Biosimilars Sales by Region (2017-2022) & (K Units)
    Table 67. Global Rituximab Biosimilars Sales by Region (2023-2028) & (K Units)
    Table 68. Global Rituximab Biosimilars Revenue by Region (2017-2022) & (USD Million)
    Table 69. Global Rituximab Biosimilars Revenue by Region (2023-2028) & (USD Million)
    Table 70. Global Rituximab Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 71. Global Rituximab Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 72. Global Rituximab Biosimilars Revenue by Type (2017-2022) & (USD Million)
    Table 73. Global Rituximab Biosimilars Revenue by Type (2023-2028) & (USD Million)
    Table 74. Global Rituximab Biosimilars Price by Type (2017-2022) & (US$/Unit)
    Table 75. Global Rituximab Biosimilars Price by Type (2023-2028) & (US$/Unit)
    Table 76. Global Rituximab Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 77. Global Rituximab Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 78. Global Rituximab Biosimilars Revenue by Application (2017-2022) & (USD Million)
    Table 79. Global Rituximab Biosimilars Revenue by Application (2023-2028) & (USD Million)
    Table 80. Global Rituximab Biosimilars Price by Application (2017-2022) & (US$/Unit)
    Table 81. Global Rituximab Biosimilars Price by Application (2023-2028) & (US$/Unit)
    Table 82. North America Rituximab Biosimilars Sales by Country (2017-2022) & (K Units)
    Table 83. North America Rituximab Biosimilars Sales by Country (2023-2028) & (K Units)
    Table 84. North America Rituximab Biosimilars Revenue by Country (2017-2022) & (USD Million)
    Table 85. North America Rituximab Biosimilars Revenue by Country (2023-2028) & (USD Million)
    Table 86. North America Rituximab Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 87. North America Rituximab Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 88. North America Rituximab Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 89. North America Rituximab Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 90. Europe Rituximab Biosimilars Sales by Country (2017-2022) & (K Units)
    Table 91. Europe Rituximab Biosimilars Sales by Country (2023-2028) & (K Units)
    Table 92. Europe Rituximab Biosimilars Revenue by Country (2017-2022) & (USD Million)
    Table 93. Europe Rituximab Biosimilars Revenue by Country (2023-2028) & (USD Million)
    Table 94. Europe Rituximab Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 95. Europe Rituximab Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 96. Europe Rituximab Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 97. Europe Rituximab Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 98. Asia-Pacific Rituximab Biosimilars Sales by Region (2017-2022) & (K Units)
    Table 99. Asia-Pacific Rituximab Biosimilars Sales by Region (2023-2028) & (K Units)
    Table 100. Asia-Pacific Rituximab Biosimilars Revenue by Region (2017-2022) & (USD Million)
    Table 101. Asia-Pacific Rituximab Biosimilars Revenue by Region (2023-2028) & (USD Million)
    Table 102. Asia-Pacific Rituximab Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 103. Asia-Pacific Rituximab Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 104. Asia-Pacific Rituximab Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 105. Asia-Pacific Rituximab Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 106. South America Rituximab Biosimilars Sales by Country (2017-2022) & (K Units)
    Table 107. South America Rituximab Biosimilars Sales by Country (2023-2028) & (K Units)
    Table 108. South America Rituximab Biosimilars Revenue by Country (2017-2022) & (USD Million)
    Table 109. South America Rituximab Biosimilars Revenue by Country (2023-2028) & (USD Million)
    Table 110. South America Rituximab Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 111. South America Rituximab Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 112. South America Rituximab Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 113. South America Rituximab Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 114. Middle East & Africa Rituximab Biosimilars Sales by Region (2017-2022) & (K Units)
    Table 115. Middle East & Africa Rituximab Biosimilars Sales by Region (2023-2028) & (K Units)
    Table 116. Middle East & Africa Rituximab Biosimilars Revenue by Region (2017-2022) & (USD Million)
    Table 117. Middle East & Africa Rituximab Biosimilars Revenue by Region (2023-2028) & (USD Million)
    Table 118. Middle East & Africa Rituximab Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 119. Middle East & Africa Rituximab Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 120. Middle East & Africa Rituximab Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 121. Middle East & Africa Rituximab Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 122. Rituximab Biosimilars Raw Material
    Table 123. Key Manufacturers of Rituximab Biosimilars Raw Materials
    Table 124. Direct Channel Pros & Cons
    Table 125. Indirect Channel Pros & Cons
    Table 126. Rituximab Biosimilars Typical Distributors
    Table 127. Rituximab Biosimilars Typical Customers
List of Figures
    Figure 1. Rituximab Biosimilars Picture
    Figure 2. Global Rituximab Biosimilars Revenue Market Share by Type in 2021
    Figure 3. 500mg
    Figure 4. 100mg
    Figure 5. Other
    Figure 6. Global Rituximab Biosimilars Revenue Market Share by Application in 2021
    Figure 7. Hospital Pharmacy
    Figure 8. Retail Pharmacy
    Figure 9. Global Rituximab Biosimilars Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
    Figure 10. Global Rituximab Biosimilars Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Rituximab Biosimilars Sales (2017-2028) & (K Units)
    Figure 12. Global Rituximab Biosimilars Price (2017-2028) & (US$/Unit)
    Figure 13. Global Rituximab Biosimilars Production Capacity (2017-2028) & (K Units)
    Figure 14. Global Rituximab Biosimilars Production Capacity by Geographic Region: 2022 VS 2028
    Figure 15. Rituximab Biosimilars Market Drivers
    Figure 16. Rituximab Biosimilars Market Restraints
    Figure 17. Rituximab Biosimilars Market Trends
    Figure 18. Global Rituximab Biosimilars Sales Market Share by Manufacturer in 2021
    Figure 19. Global Rituximab Biosimilars Revenue Market Share by Manufacturer in 2021
    Figure 20. Rituximab Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 21. Top 3 Rituximab Biosimilars Manufacturer (Revenue) Market Share in 2021
    Figure 22. Top 6 Rituximab Biosimilars Manufacturer (Revenue) Market Share in 2021
    Figure 23. Global Rituximab Biosimilars Sales Market Share by Region (2017-2028)
    Figure 24. Global Rituximab Biosimilars Revenue Market Share by Region (2017-2028)
    Figure 25. North America Rituximab Biosimilars Revenue (2017-2028) & (USD Million)
    Figure 26. Europe Rituximab Biosimilars Revenue (2017-2028) & (USD Million)
    Figure 27. Asia-Pacific Rituximab Biosimilars Revenue (2017-2028) & (USD Million)
    Figure 28. South America Rituximab Biosimilars Revenue (2017-2028) & (USD Million)
    Figure 29. Middle East & Africa Rituximab Biosimilars Revenue (2017-2028) & (USD Million)
    Figure 30. Global Rituximab Biosimilars Sales Market Share by Type (2017-2028)
    Figure 31. Global Rituximab Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 32. Global Rituximab Biosimilars Price by Type (2017-2028) & (US$/Unit)
    Figure 33. Global Rituximab Biosimilars Sales Market Share by Application (2017-2028)
    Figure 34. Global Rituximab Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 35. Global Rituximab Biosimilars Price by Application (2017-2028) & (US$/Unit)
    Figure 36. North America Rituximab Biosimilars Sales Market Share by Type (2017-2028)
    Figure 37. North America Rituximab Biosimilars Sales Market Share by Application (2017-2028)
    Figure 38. North America Rituximab Biosimilars Sales Market Share by Country (2017-2028)
    Figure 39. North America Rituximab Biosimilars Revenue Market Share by Country (2017-2028)
    Figure 40. United States Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Canada Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Mexico Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Europe Rituximab Biosimilars Sales Market Share by Type (2017-2028)
    Figure 44. Europe Rituximab Biosimilars Sales Market Share by Application (2017-2028)
    Figure 45. Europe Rituximab Biosimilars Sales Market Share by Country (2017-2028)
    Figure 46. Europe Rituximab Biosimilars Revenue Market Share by Country (2017-2028)
    Figure 47. Germany Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. France Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. United Kingdom Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Russia Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Italy Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Asia-Pacific Rituximab Biosimilars Sales Market Share by Region (2017-2028)
    Figure 53. Asia-Pacific Rituximab Biosimilars Sales Market Share by Application (2017-2028)
    Figure 54. Asia-Pacific Rituximab Biosimilars Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Rituximab Biosimilars Revenue Market Share by Region (2017-2028)
    Figure 56. China Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Japan Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Korea Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. India Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Southeast Asia Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Australia Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South America Rituximab Biosimilars Sales Market Share by Type (2017-2028)
    Figure 63. South America Rituximab Biosimilars Sales Market Share by Application (2017-2028)
    Figure 64. South America Rituximab Biosimilars Sales Market Share by Country (2017-2028)
    Figure 65. South America Rituximab Biosimilars Revenue Market Share by Country (2017-2028)
    Figure 66. Brazil Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Argentina Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Middle East & Africa Rituximab Biosimilars Sales Market Share by Type (2017-2028)
    Figure 69. Middle East & Africa Rituximab Biosimilars Sales Market Share by Application (2017-2028)
    Figure 70. Middle East & Africa Rituximab Biosimilars Sales Market Share by Region (2017-2028)
    Figure 71. Middle East & Africa Rituximab Biosimilars Revenue Market Share by Region (2017-2028)
    Figure 72. Turkey Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Egypt Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Saudi Arabia Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. South Africa Rituximab Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Manufacturing Cost Structure Analysis of Rituximab Biosimilars in 2021
    Figure 77. Manufacturing Process Analysis of Rituximab Biosimilars
    Figure 78. Rituximab Biosimilars Industrial Chain
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Companies Mentioned

Amgen
AryoGen Pharmed
Biocad
Cadila Pharmaceuticals
Celltrion
Dr Reddy’s Laboratories
Teva
Hetero Group
Innovent Biologics
Intas Biopharmaceuticals
Mylan
Probiomed
TRPharma
Zenotech Laboratories